Fate Therapeutics (FATE) Return on Sales (2016 - 2025)
Fate Therapeutics (FATE) has disclosed Return on Sales for 14 consecutive years, with 23.74% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Sales rose 737.0% year-over-year to 23.74%, compared with a TTM value of 20.56% through Dec 2025, down 640.0%, and an annual FY2025 reading of 20.56%, down 640.0% over the prior year.
- Return on Sales was 23.74% for Q4 2025 at Fate Therapeutics, down from 18.47% in the prior quarter.
- Across five years, Return on Sales topped out at 0.42% in Q1 2023 and bottomed at 62.36% in Q2 2023.
- Average Return on Sales over 5 years is 15.21%, with a median of 10.77% recorded in 2024.
- The sharpest move saw Return on Sales plummeted -5792bps in 2023, then surged 5642bps in 2024.
- Year by year, Return on Sales stood at 4.05% in 2021, then surged by 66bps to 1.39% in 2022, then plummeted by -1778bps to 26.05% in 2023, then decreased by -19bps to 31.12% in 2024, then increased by 24bps to 23.74% in 2025.
- Business Quant data shows Return on Sales for FATE at 23.74% in Q4 2025, 18.47% in Q3 2025, and 17.85% in Q2 2025.